Indian Mogul Kiran Mazumdar-Shaw’s Biocon Acquistion Bargain Worths Biologics System At $5.5 Billion
Researcher at Biocon R&D center in Bangalore, India. Baikang Baikang— Regulated by Indian pharmaceutical billionaires Kiran Majumdar-Shaw– is obtaining the rest of independently held subsidiary Biocon Biologics to settle its biosimilars and